Opthea Limited (ASX:OPT)
0.6000
-0.0050 (-0.83%)
At close: Mar 14, 2025
Opthea Market Cap
Opthea has a market cap or net worth of 738.77 million as of December 26, 2025. Its market cap has increased by 61.54% in one year.
Market Cap
738.77M
Enterprise Value
885.55M
Revenue
222.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since May 13, 1996, Opthea's market cap has increased from 39.30M to 738.77M, an increase of 1,779.68%. That is a compound annual growth rate of 10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 14, 2025 | 738.77M | -25.92% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | 648.32M | -19.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.72B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.03B |
| Mesoblast | 3.72B |